![Adi Barzel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Adi Barzel was the founder of LogicBio Therapeutics, Inc. where he held the title of Chief Scientific Officer from 2014 to 2018.
Dr. Barzel is also the founder of Tabby Therapeutics Ltd.
Precedenti posizioni note di Adi Barzel
Società | Posizione | Fine |
---|---|---|
LOGICBIO THERAPEUTICS, INC. | Fondatore | 22/05/2018 |
Tabby Therapeutics Ltd.
![]() Tabby Therapeutics Ltd. BiotechnologyHealth Technology Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad. | Fondatore | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
LogicBio Therapeutics, Inc.
![]() LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
Tabby Therapeutics Ltd.
![]() Tabby Therapeutics Ltd. BiotechnologyHealth Technology Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad. | Health Technology |
- Borsa valori
- Insiders
- Adi Barzel